These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Recommendations from treatment guidelines for schizophrenia regarding monitoring of side effects of antipsychotics: brief review. Kozumplik O; Uzun S Psychiatr Danub; 2009 Mar; 21(1):95-8. PubMed ID: 19270630 [TBL] [Abstract][Full Text] [Related]
5. The patient's perspective on medicines in mental illness. Shooter M BMJ; 2003 Oct; 327(7419):824-6. PubMed ID: 14551067 [No Abstract] [Full Text] [Related]
6. [Safeguarding the prescription of antipsychotics in the paediatric population: A French multicentric study in a treatment naïve population]. Menard ML; Askénazy F; Auby P; Bonnot O; Cohen D Encephale; 2013 Oct; 39(5):313-4. PubMed ID: 23809174 [No Abstract] [Full Text] [Related]
7. Clinical monitoring and management of the metabolic syndrome in patients receiving atypical antipsychotic medications. Hasnain M; Vieweg WV; Fredrickson SK; Beatty-Brooks M; Fernandez A; Pandurangi AK Prim Care Diabetes; 2009 Feb; 3(1):5-15. PubMed ID: 19083283 [TBL] [Abstract][Full Text] [Related]
8. Introduction: evaluating the evidence: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and beyond. Nasrallah HA J Clin Psychiatry; 2007; 68 Suppl 1():3-4. PubMed ID: 17286521 [No Abstract] [Full Text] [Related]
10. Sell v. United States: the appropriate standard for involuntarily administering antipsychotic drugs to dangerous detainees for trial. Borger BA Seton Hall Law Rev; 2005; 35(3):1099-120. PubMed ID: 16270457 [No Abstract] [Full Text] [Related]
11. Substituting traditional antipsychotics with risperidone for individuals with mental retardation. Simon EW; Blubaugh KM; Pippidis M Ment Retard; 1996 Dec; 34(6):359-66. PubMed ID: 8990820 [TBL] [Abstract][Full Text] [Related]
12. Compliance with medication regimens for mental and physical disorders. Cramer JA; Rosenheck R Psychiatr Serv; 1998 Feb; 49(2):196-201. PubMed ID: 9575004 [TBL] [Abstract][Full Text] [Related]
13. Antipsychotic medications in children and adolescents. Findling RL; Grcevich SJ; Lopez I; Schulz SC J Clin Psychiatry; 1996; 57 Suppl 9():19-23. PubMed ID: 8823346 [TBL] [Abstract][Full Text] [Related]
14. Managed care's atypical response. New antipsychotics show promise, but are they getting into enough hands? Waldron T Behav Healthc Tomorrow; 1999 Apr; 8(2):28-31. PubMed ID: 10351297 [No Abstract] [Full Text] [Related]
16. Medication samples and drug compliance. Bastiaens L; Chowdhury S; Gitelman L Psychiatr Serv; 2000 Jun; 51(6):819. PubMed ID: 10828124 [No Abstract] [Full Text] [Related]
17. Improving drug knowledge in psychiatric patients. Smith JE J Psychiatr Nurs Ment Health Serv; 1981 Apr; 19(4):16-8. PubMed ID: 6101240 [No Abstract] [Full Text] [Related]
18. Cocaine and amphetamine use in patients with psychiatric illness: a randomized trial of typical antipsychotic continuation or discontinuation. Brown ES; Nejtek VA; Perantie DC; Rajan Thomas N; Rush AJ J Clin Psychopharmacol; 2003 Aug; 23(4):384-8. PubMed ID: 12920415 [TBL] [Abstract][Full Text] [Related]
19. The myth of the magic antipsychotic. Moncrieff J Ment Health Today; 2008 Jun; ():18-9, 22. PubMed ID: 18663800 [No Abstract] [Full Text] [Related]
20. Does patient education enhance compliance with clozapine? A preliminary investigation. Gray R J Psychiatr Ment Health Nurs; 2000 Jun; 7(3):285-6. PubMed ID: 11249323 [No Abstract] [Full Text] [Related] [Next] [New Search]